170 related articles for article (PubMed ID: 30275689)
1. Proton pump inhibitors use is associated with a lower risk of acute exacerbation and mortality in patients with coexistent COPD and GERD.
Su VY; Liao HF; Perng DW; Chou YC; Hsu CC; Chou CL; Chang YL; Yen JC; Chen TJ; Chou TC
Int J Chron Obstruct Pulmon Dis; 2018; 13():2907-2915. PubMed ID: 30275689
[TBL] [Abstract][Full Text] [Related]
2. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of pulmonary tuberculosis in patients with gastroesophageal reflux disease.
Fan WC; Ou SM; Feng JY; Hu YW; Yeh CM; Su VY; Hu LY; Chien SH; Su WJ; Chen TJ; Liu CJ
Int J Tuberc Lung Dis; 2016 Feb; 20(2):265-70. PubMed ID: 26792483
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitors for chronic obstructive pulmonary disease.
Kikuchi S; Imai H; Tani Y; Tajiri T; Watanabe N
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013113. PubMed ID: 32844430
[TBL] [Abstract][Full Text] [Related]
5. Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study.
Kim J; Lee JH; Kim Y; Kim K; Oh YM; Yoo KH; Rhee CK; Yoon HK; Kim YS; Park YB; Lee SW; Lee SD
BMC Pulm Med; 2013 Aug; 13():51. PubMed ID: 23927016
[TBL] [Abstract][Full Text] [Related]
6. Effects of gastroesophageal reflux disease treatment with proton pump inhibitors on the risk of acute exacerbation and pneumonia in patients with COPD.
Kang J; Lee R; Lee SW
Respir Res; 2023 Mar; 24(1):75. PubMed ID: 36906585
[TBL] [Abstract][Full Text] [Related]
7. Newly diagnosed gastroesophageal reflux disease increased the risk of acute exacerbation of chronic obstructive pulmonary disease during the first year following diagnosis--a nationwide population-based cohort study.
Lin YH; Tsai CL; Chien LN; Chiou HY; Jeng C
Int J Clin Pract; 2015 Mar; 69(3):350-7. PubMed ID: 25359162
[TBL] [Abstract][Full Text] [Related]
8. Associations between gastro-oesophageal reflux, its management and exacerbations of chronic obstructive pulmonary disease.
Benson VS; Müllerová H; Vestbo J; Wedzicha JA; Patel A; Hurst JR;
Respir Med; 2015 Sep; 109(9):1147-54. PubMed ID: 26166017
[TBL] [Abstract][Full Text] [Related]
9. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.
Ho TW; Tsai YJ; Ruan SY; Huang CT; Lai F; Yu CJ;
PLoS One; 2014; 9(12):e114866. PubMed ID: 25490399
[TBL] [Abstract][Full Text] [Related]
10. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
Schey R; Alla SP; Midani D; Parkman HP
Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
[TBL] [Abstract][Full Text] [Related]
11. Fewer acute respiratory infection episodes among patients receiving treatment for gastroesophageal reflux disease.
Lin HC; Xirasagar S; Chung SD; Huang CC; Tsai MC; Chen CH
PLoS One; 2017; 12(2):e0172436. PubMed ID: 28222168
[TBL] [Abstract][Full Text] [Related]
12. Role of gastroesophageal reflux symptoms in exacerbations of COPD.
Rascon-Aguilar IE; Pamer M; Wludyka P; Cury J; Coultas D; Lambiase LR; Nahman NS; Vega KJ
Chest; 2006 Oct; 130(4):1096-101. PubMed ID: 17035443
[TBL] [Abstract][Full Text] [Related]
13. Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort.
Martinez CH; Okajima Y; Murray S; Washko GR; Martinez FJ; Silverman EK; Lee JH; Regan EA; Crapo JD; Curtis JL; Hatabu H; Han MK;
Respir Res; 2014 Jun; 15(1):62. PubMed ID: 24894541
[TBL] [Abstract][Full Text] [Related]
14. Impact of gastroesophageal reflux on longitudinal lung function and quantitative computed tomography in the COPDGene cohort.
Baldomero AK; Wendt CH; Petersen A; Gaeckle NT; Han MK; Kunisaki KM;
Respir Res; 2020 Aug; 21(1):203. PubMed ID: 32746820
[TBL] [Abstract][Full Text] [Related]
15. Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exacerbation requiring hospitalization: a disease risk score-matched nested case-control study.
Wang MT; Lai JH; Huang YL; Kuo FC; Wang YH; Tsai CL; Tu MY
Respir Res; 2020 Dec; 21(1):319. PubMed ID: 33267895
[TBL] [Abstract][Full Text] [Related]
16. Determining prognosis in acute exacerbation of COPD.
Flattet Y; Garin N; Serratrice J; Perrier A; Stirnemann J; Carballo S
Int J Chron Obstruct Pulmon Dis; 2017; 12():467-475. PubMed ID: 28203070
[TBL] [Abstract][Full Text] [Related]
17. Patients with Cerebral Stroke Have an Increased Risk of Gastroesophageal Reflux Disease: A Population-Based Cohort Study.
Chang CS; Chen HJ; Liao CH
J Stroke Cerebrovasc Dis; 2018 May; 27(5):1267-1274. PubMed ID: 29325919
[TBL] [Abstract][Full Text] [Related]
18. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of gastroesophageal reflux disease and swallowing dysfunction in COPD.
Mokhlesi B
Am J Respir Med; 2003; 2(2):117-21. PubMed ID: 14720011
[TBL] [Abstract][Full Text] [Related]
20. Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesis.
Nason KS; Wichienkuer PP; Awais O; Schuchert MJ; Luketich JD; O'Rourke RW; Hunter JG; Morris CD; Jobe BA
Arch Surg; 2011 Jul; 146(7):851-8. PubMed ID: 21768433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
